TuHURA Biosciences, Inc. HURA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $0— | $0— | $0— | $0— | $0— | ||
| $5.23M-13.6% | $6.06M+21.9% | $4.97M+0.8% | $4.93M+7.5% | $4.58M+15.2% | ||
| $2.3M— | —— | $1.76M-64.4% | $4.95M+145% | $2.02M+57.8% | ||
| $7.53M-7.9% | $8.17M+21.5% | $6.73M-31.9% | $9.88M+40.7% | $7.02M+23.2% | ||
| $27.97K-95.4% | $608.75K+3,582% | $16.53K— | —— | —— | ||
| -$6.7K-100% | $1.41M+479% | -$372.85K-206% | $352.12K-0.2% | $352.65K-90.9% | ||
| -$7.54M-11.5% | -$6.76M+4.8% | -$7.1M+25.4% | -$9.52M-42.9% | -$6.66M-11.2% | ||
| -$0.130.0% | -$0.13+7.1% | -$0.14+33.3% | -$0.21-40.0% | -$0.15— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is TuHURA Biosciences, Inc. profitable?
- TuHURA Biosciences, Inc. is not currently profitable: it reported a net loss of $30.9M over the trailing twelve months.
- What is TuHURA Biosciences, Inc.'s earnings per share?
- TuHURA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-0.61.
- Where does TuHURA Biosciences, Inc.'s income statement data come from?
- Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.